Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 4626 - 4650 of 6489 in total

PCLX-001

PCLX-001 is a first-in-kind N-Myristoyltransferase (NMT) inhibitor being developed by Pacylex Pharmaceuticals (https://pacylex.com). Current studies have shown that PCLX-001 works differently than other known cancer drugs and has high activity and positive results in breast, lung, bladder and pancreas cancers.
Investigational

2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione

Experimental

(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine

Experimental

2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE

Experimental

2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE

Experimental

N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE

Experimental

Inositol 1,3,4,5-Tetrakisphosphate

Experimental

10-formyl-5,8,10-trideazafolic acid

Experimental

(3s)-2,3,4,5-Tetrahydropyridin-3-Amine

Experimental

2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE

Experimental

CRx-119

CRx-119 is a novel synergistic combination drug candidate discovered using the CombinatoRx combination High Throughput Screening (cHTS(TM)) technology with potential therapeutic use in a broad range of immuno-inflammatory conditions. CRx-119 is a combination of a low dose of the steroid prednisolone, 3mg, and amoxapine.
Investigational

Berubicin

Investigational
Matched Iupac: … (8S,10S)-10-{[(2R,4S,5S,6S)-4-amino-5-(benzyloxy)-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl …

4-Bromo-2,5-dimethoxyamphetamine

Experimental
Illicit

3,4-Xylenol

Experimental

Mubodina

Mubodina is an investigational drug developed by Adienne Pharma & Biotech. It is a recombinant human minibody directed against complement component C5. It was investigated in various conditions including primary membranoproliferative glomerulonephritis and typical hemolytic uremic syndrome.
Investigational

Ciliary neurotrophic factor

NT-501 is an intraocular implant that contains human cells that have been genetically modified to secrete ciliary neurotrophic factor (CNTF). It is under investigation for the treatment of retinitis pigmentosa and age-related macular degeneration.
Investigational

Oxidized coenzyme A

Experimental
Matched Iupac: … {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-3-[(2-{[2-(hydroxysulfanyl …

(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol

Experimental

Bexotegrast

Investigational

2,3,4,5,6-Pentafluorobenzyl Alcohol

Experimental

10-Propargyl-5,8-Dideazafolic Acid

Experimental

OCTANE-1,3,5,7-TETRACARBOXYLIC ACID

Experimental

Homogentisic acid

Experimental

Azapentacene

Experimental

Recombinant neuroglobin

Investigational
Displaying drugs 4626 - 4650 of 6489 in total